Tags : Fintepla (Fenfluramine)

Clinical Trials

Zogenix Presents Results of Fintepla’s (fenfluramine) Study Highlighting the Impact

Shots: The P-III study is designed to assess caregivers’ perspectives on the long-term seizure & non-seizure-related benefits of Fintepla on patients with Dravet syndrome and on their caregivers and families Results: seizure-related benefits noted by caregivers include a reduction in frequency, seizure activity, and shorter recovery time while non-seizure benefits include improvements in executive functions […]Read More